Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy

BACKGROUND: Radium-223 is a registered treatment option for symptomatic bone metastatic castration-resistant prostate cancer (mCRPC). Aim of this multicenter, prospective observational cohort study was to evaluate health-related quality of life (HR-QoL), psychological distress and fatigue in mCRPC p...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Doelen, Maarten J., Oving, Irma M., Wyndaele, Dirk N. J., van Basten, Jean-Paul, Terheggen, Frederiek, van de Luijtgaarden, Addy C. M., Oyen, Wim. J. G., van Schelven, W. Dick, van den Berkmortel, Franchette, Mehra, Niven, Janssen, Marcel J. R., Prins, Judith B., Gerritsen, Winald R., Custers, José A. E., van Oort, Inge M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023564/
https://www.ncbi.nlm.nih.gov/pubmed/35804188
http://dx.doi.org/10.1038/s41391-022-00569-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023564/
https://www.ncbi.nlm.nih.gov/pubmed/35804188
http://dx.doi.org/10.1038/s41391-022-00569-8

Ejemplares similares